Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06193174 |
|
Recruitment Status :
Not yet recruiting
First Posted : January 5, 2024
Last Update Posted : January 19, 2024
|
Sponsor:
University of Alabama at Birmingham
Information provided by (Responsible Party):
James Markert, MD, University of Alabama at Birmingham
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | August 14, 2026 |
| Estimated Study Completion Date : | August 14, 2027 |